FDA Approved: NILUTAMIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved ANI Pharmaceuticals' supplemental application for nilutamide, confirming regulatory approval for an updated product submission.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Nilutamide (Nilutamide)

Snippet

SUPPL AP for NILUTAMIDE (NILUTAMIDE)